Logo image of CNNE

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

NYSE:CNNE - New York Stock Exchange, Inc. - US13765N1072 - Common Stock

19.06  -0.11 (-0.57%)

After market: 19.06 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CNNE. CNNE was compared to 101 industry peers in the Financial Services industry. CNNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CNNE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.
CNNE had a negative operating cash flow in the past year.
In multiple years CNNE reported negative net income over the last 5 years.
In the past 5 years CNNE always reported negative operating cash flow.
CNNE Yearly Net Income VS EBIT VS OCF VS FCFCNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

1.2 Ratios

CNNE's Return On Assets of -14.14% is on the low side compared to the rest of the industry. CNNE is outperformed by 90.10% of its industry peers.
CNNE has a worse Return On Equity (-17.16%) than 86.14% of its industry peers.
Industry RankSector Rank
ROA -14.14%
ROE -17.16%
ROIC N/A
ROA(3y)-10.91%
ROA(5y)1.93%
ROE(3y)-12.61%
ROE(5y)2.92%
ROIC(3y)N/A
ROIC(5y)N/A
CNNE Yearly ROA, ROE, ROICCNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

1.3 Margins

Looking at the Gross Margin, with a value of 18.08%, CNNE is doing worse than 61.39% of the companies in the same industry.
CNNE's Gross Margin has improved in the last couple of years.
CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.26%
GM growth 5Y10.11%
CNNE Yearly Profit, Operating, Gross MarginsCNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

More info and screens

6

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNNE has been reduced compared to 1 year ago.
CNNE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNNE has a worse debt to assets ratio.
CNNE Yearly Shares OutstandingCNNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
CNNE Yearly Total Debt VS Total AssetsCNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

CNNE has an Altman-Z score of 2.28. This is not the best score and indicates that CNNE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.28, CNNE is in the better half of the industry, outperforming 78.22% of the companies in the same industry.
CNNE has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CNNE has a better Debt to Equity ratio (0.10) than 82.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACC9.36%
CNNE Yearly LT Debt VS Equity VS FCFCNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

CNNE has a Current Ratio of 2.55. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
CNNE has a better Current ratio (2.55) than 80.20% of its industry peers.
CNNE has a Quick Ratio of 2.55. This indicates that CNNE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CNNE (2.55) is better than 81.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
CNNE Yearly Current Assets VS Current LiabilitesCNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CNNE have decreased strongly by -58.22% in the last year.
CNNE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.83%.
The Revenue for CNNE have been decreasing by -13.06% on average. This is quite bad
EPS 1Y (TTM)-58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.91%
Revenue 1Y (TTM)-23.83%
Revenue growth 3Y-0.9%
Revenue growth 5Y-13.06%
Sales Q2Q%-20.68%

3.2 Future

CNNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.33% yearly.
CNNE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.76% yearly.
EPS Next Y-3.53%
EPS Next 2Y31.47%
EPS Next 3Y22.33%
EPS Next 5YN/A
Revenue Next Year-23.85%
Revenue Next 2Y-12.55%
Revenue Next 3Y-5.76%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNNE Yearly Revenue VS EstimatesCNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CNNE Yearly EPS VS EstimatesCNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNNE Price Earnings VS Forward Price EarningsCNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNNE Per share dataCNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 22.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.47%
EPS Next 3Y22.33%

More info and screens

2

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 2.50%.
Compared to an average industry Dividend Yield of 3.66, CNNE pays a bit more dividend than its industry peers.
CNNE's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

CNNE is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNNE Yearly Dividends per shareCNNE Yearly Dividends per shareYearly Dividends per share 2021 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2Y31.47%
EPS Next 3Y22.33%
CNNE Yearly Income VS Free CF VS DividendCNNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

More info and screens

CANNAE HOLDINGS INC

NYSE:CNNE (1/17/2025, 8:04:00 PM)

After market: 19.06 0 (0%)

19.06

-0.11 (-0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners83.18%
Inst Owner Change-0.01%
Ins Owners8.69%
Ins Owner Change0.08%
Market Cap1.20B
Analysts86.67
Price Target28.56 (49.84%)
Short Float %1.5%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-653.97%
Min EPS beat(2)-1308.4%
Max EPS beat(2)0.45%
EPS beat(4)1
Avg EPS beat(4)-490.39%
Min EPS beat(4)-1308.4%
Max EPS beat(4)0.45%
EPS beat(8)2
Avg EPS beat(8)-528.07%
EPS beat(12)3
Avg EPS beat(12)-3082.24%
EPS beat(16)5
Avg EPS beat(16)-930.47%
Revenue beat(2)2
Avg Revenue beat(2)4.48%
Min Revenue beat(2)3.29%
Max Revenue beat(2)5.68%
Revenue beat(4)2
Avg Revenue beat(4)-5.12%
Min Revenue beat(4)-15.41%
Max Revenue beat(4)5.68%
Revenue beat(8)2
Avg Revenue beat(8)-6.31%
Revenue beat(12)2
Avg Revenue beat(12)-7.8%
Revenue beat(16)4
Avg Revenue beat(16)-5.51%
PT rev (1m)0%
PT rev (3m)3.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.59
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.66
EV/EBITDA N/A
EPS(TTM)-4.81
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS7.36
BVpS30.03
TBVpS28.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.14%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.08%
FCFM N/A
ROA(3y)-10.91%
ROA(5y)1.93%
ROE(3y)-12.61%
ROE(5y)2.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.26%
GM growth 5Y10.11%
F-Score4
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.72%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 2.28
F-Score4
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)55.75%
Cap/Depr(5y)58.36%
Cap/Sales(3y)1.92%
Cap/Sales(5y)2.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.91%
EPS Next Y-3.53%
EPS Next 2Y31.47%
EPS Next 3Y22.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.83%
Revenue growth 3Y-0.9%
Revenue growth 5Y-13.06%
Sales Q2Q%-20.68%
Revenue Next Year-23.85%
Revenue Next 2Y-12.55%
Revenue Next 3Y-5.76%
Revenue Next 5YN/A
EBIT growth 1Y7.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-85.53%
EBIT Next 3Y10.32%
EBIT Next 5YN/A
FCF growth 1Y49.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.66%
OCF growth 3YN/A
OCF growth 5YN/A